UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045548
Receipt number R000051989
Scientific Title Objective assessment of nocturnal itching utilizing an information and communication technology equipment in children with atopic dermatitis. Fundamental Unveiling of Monitoring technology for Itching in children with atopic dermatitis
Date of disclosure of the study information 2021/09/30
Last modified on 2023/03/29 09:00:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Objective assessment of nocturnal itching utilizing an information and communication technology equipment in children with atopic dermatitis. Fundamental Unveiling of Monitoring technology for Itching in children with atopic dermatitis

Acronym

Objective assessment of itching in children with atopic dermatitis utilizing Apple Watch

Scientific Title

Objective assessment of nocturnal itching utilizing an information and communication technology equipment in children with atopic dermatitis. Fundamental Unveiling of Monitoring technology for Itching in children with atopic dermatitis

Scientific Title:Acronym

Objective assessment of itching in children with atopic dermatitis

Region

Japan


Condition

Condition

atopic dermatitis

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To obtain quantitative data on nighttime scratching behavior in pediatric patients with atopic dermatitis using an ICT device (Itch Tracker with Apple Watch)

Basic objectives2

Others

Basic objectives -Others

To analyze relationship between data obtained from ICT device and skin rash severity, quality of life, inflammatory markers, and other clinical factors

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To analyze the relationship between the data measured by Itch Tracker with Apple Watch and the following indicators
1. severity of skin rash (EASI)
2.Patient assessment of severity (POEM)
3.Quality of life (CDLQI)
4.Th2 inflammatory markers (SCCA2, TARC)
5. patient assessment of itch (VAS, NRS, itch diary)

Key secondary outcomes

Changes in treatment and its responsiveness before and after quantitative nighttime curettage behavior


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Children aged 6-15 years who have been diagnosed with atopic dermatitis according to Hanifin & Rajka's criteria and are being treated at our clinic, and who are able to wear the Apple Watch at night.
(2) Children who have given their consent to participate in this study.

Key exclusion criteria

(1) If consent for the research is not obtained
(2) When the principal investigator or sub-investigator judges that participation in this research is not appropriate.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Fumiko
Middle name
Last name Iwai

Organization

National Hospital Organization Mie National Hospital

Division name

Department of Allergy

Zip code

5140125

Address

359, Osato Kubota-cho, Tsu City

TEL

059-232-2531

Email

fu_mi_n_1986@yahoo.co.jp


Public contact

Name of contact person

1st name Fumiko
Middle name
Last name Iwai

Organization

National Hospital Organization Mie National Hospital

Division name

Department of Allergy

Zip code

5140125

Address

359, Osato Kubota-cho, Tsu City

TEL

059-232-2531

Homepage URL


Email

fu_mi_n_1986@yahoo.co.jp


Sponsor or person

Institute

National Hospital Organization Mie National Hospital

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Mie National Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Mie Hospital

Address

359, Osato Kubota-cho, Tsu City

Tel

059-232-2531

Email

mieclinicalresearch@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構三重病院


Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 07 Month 19 Day

Date of IRB

2021 Year 07 Month 21 Day

Anticipated trial start date

2021 Year 10 Month 04 Day

Last follow-up date

2023 Year 01 Month 31 Day

Date of closure to data entry

2023 Year 02 Month 28 Day

Date trial data considered complete

2023 Year 04 Month 29 Day

Date analysis concluded

2023 Year 09 Month 30 Day


Other

Other related information

Scratching behavior of patients with atopic dermatitis captured by ICT equipment will be analyzed for association with subjective evaluation of itching by patients and various biomarkers of atopic dermatitis


Management information

Registered date

2021 Year 09 Month 22 Day

Last modified on

2023 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051989